Notice for International Patients & Caregivers
English summary does not mean the trial enrolls international patients. Multiple myeloma interventional clinical trials in China typically require valid Chinese resident identity/national healthcare insurance and strict adherence to China's Human Genetic Resources Administration regulations.
Guangdong Multiple Myeloma Active Trials & Centers
As of 2026-09-04, there are 47 active clinical trials for multiple myeloma hosted across 36 tertiary medical centers in Guangdong (including Sun Yat-sen University Cancer Center, Peking University Shenzhen Hospital, Sun Yat-sen University Cancer Center, etc.).
Participating Medical Centers (36)
Active Studies in Guangdong (47)
Population synthesized by CMDNShowing 0 published English records of 47 registry trials.
All 47 local registry studies currently have Chinese-only filings. Verified English summaries will be published upon regulatory audit.
